Familial Dilated Cardiomyopathy

Dilated cardiomyopathy is a disease of the muscle of the heart which results in an enlarged heart with thin walls and a large pumping chamber. Dilated cardiomyopathy has many potential causes, including heart attacks, heart valve disease, high blood pressure, infections, and drugs toxic to the heart.

Condition Spotlight

Stanford Hospital & Clinics: Dilated Cardiomyopathy Explained Watch Video

Clinical Trials for Familial Dilated Cardiomyopathy

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Closed Trials

Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy Familial Dilated Cardiomyopathy, Heart Failure , Hypertrophic Cardiomyopathy

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure Arrhythmia, Atrial Fibrillation (AFib), Hypertrophic Cardiomyopathy

Study of Exercise Training in Hypertrophic Cardiomyopathy Familial Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy,

A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy Cardiomyopathy, Familial Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy

Implantable Cardioverter-Defibrillator Use in the VA System Cardiomyopathy, Familial Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy

An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) Familial Dilated Cardiomyopathy, Heart Failure , Hypertrophic Cardiomyopathy